儿科瘤学家关于转诊CAR-T治疗的观点:混合方法试点研究
Anurekha G Hall1,2, Devan M Duenas3, Jenna Voutsinas2
1Division of Hematology and Oncology, University of Washington, Seattle Children's Hospital, Seattle, WA, USA.
JNCI cancer spectrum
|July 30, 2024
概括
近40%的瘤学家在化学抗原受体T细胞 (CAR-T) 治疗推中考虑非临床因素,可能引入偏见. 与CAR-T中心的正式合作伙伴关系可能有助于克服转诊障碍.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 化学抗原受体T细胞 (CAR-T) 治疗转诊是复杂的,涉及多个步骤和瘤学家.
- 瘤学家的转诊决定可能受到各种因素的影响,可能引入偏见.
研究的目的:
- 探索瘤学家推治疗CAR-T疗法的实践.
- 确定影响这些转介决定和潜在偏见的因素.
主要方法:
- 调查被发送给瘤学家,这些瘤学家之前曾将患者转诊CAR-T疗法.
- 描述性统计和多变量分析检查了转诊实践.
- 半结构面试与瘤学家的一个子集进行了专题分析.
主要成果:
- 38%的瘤学家认为非临床特征 (如种族,保险) 对CAR-T转诊决定具有影响力.
- 西班牙裔瘤学家和那些在较低体积的中心报告较少熟悉CAR-T疗法.
- 常见的采访主题包括转介障碍,与CAR-T中心建立关系的重要性以及沟通问题.
结论:
- 相当一部分瘤学家考虑非临床因素,引发了对CAR-T治疗转诊潜在偏差的担忧.
- 瘤学家和CAR-T治疗中心之间的正式合作伙伴关系可以减轻转诊障碍并改善转诊过程.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy
498
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
498
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K


